Why BeyondSpring Inc.’s (BYSI) Stock Is Down 6.00%
As of Wednesday, July 22, BeyondSpring Inc.’s BYSI share price has dipped by 6.00%, which has investors questioning if this is right time to buy.Rosalio Madrigal
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on developing and selling clinical-stage biopharmaceutical therapies focused on oncology and immunology. The company operates through two segments: the Plinabulin pipeline and the TPD platform. The company’s lead asset is Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia (CIN). It also develops Plinabulin in combination with Plinabulin+docetaxel vs. docetaxel alone for the treatment of NSCLC and epidermal growth factor receptor wild type. In addition, the company develops Plinabulin in combination with various immuno-oncology agents and chemotherapy and radiation; nivolumab, a PD-1 antibody that has completed phase 1 clinical trials for the treatment of non-small cell lung cancer; ipilimumab, a CTLA-4 antibody for the treatment of extensive-stage small cell lung cancer (ES-SCLC); in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers; and pembrolizumab, etoposide, and platinum to treat extensive-stage small cell lung cancer. Further, it engages in the development of three small-molecule immune agents in preclinical stages; and a drug discovery platform to develop therapeutic agents from internal research and development efforts and from collaboration. The company was founded in 2010 and is headquartered in Florham Park, New Jersey.
Commentary & Analysis
Why BeyondSpring Inc.’s (BYSI) Stock Is Down 8.38%
As of Thursday, July 09, BeyondSpring Inc.’s BYSI share price has dipped by 8.38%, which has investors questioning if this is right time to buy.Rosalio Madrigal
Why BeyondSpring Inc.’s (BYSI) Stock Is Down 6.41%
As of Monday, July 06, BeyondSpring Inc.’s BYSI share price has dipped by 6.41%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Why BeyondSpring Inc.’s (BYSI) Stock Is Down 5.59%
As of Tuesday, June 30, BeyondSpring Inc.’s BYSI share price has dipped by 5.59%, which has investors questioning if this is right time to buy.Rosalio Madrigal
Why BeyondSpring Inc.’s (BYSI) Stock Is Up 5.10%
As of Monday, June 15, BeyondSpring Inc.’s BYSI share price has surged by 5.10%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Financial Summary
| Share Statistics | BYSI | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $29.6 | $292.6 | 12% |
|
| Shares Out (Mil) | 41.1 | 54.4 | 43% |
|
| Institutional Ownership | 34.2% | 93.2% | 14% |
|
| Float (Mil) | 32.0 | 40.2 | 37% |
|
| Beta | na | 0.94 | na |
|
| Avg Daily Volume (000s) | 4,059 | 544 | 91% |
|
| Price Change (52-week) |
(58.1%) | 59.7% | 11% |
|
| Growth | BYSI | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 13.6% | na |
|
| Net Income (5yr) | 56.1% | (10.1%) | 95% |
|
| EPS (5yr) | 58.5% | 16.0% | 95 |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | (15.3%) | (15.6%) | 50% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | BYSI | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $37 | na |
|
| Net Income (TTM) (Mil) | ($7) | ($43) | 32% |
|
| EPS (TTM) | ($0.164) | ($1.400) | 34% |
|
| Operating Cash Flow (TTM) (Mil) | ($17) | ($31) | 16% |
|
| Net Cash Flow (TTM) (Mil) | ($18) | $2 | 27% |
|
| Long-Term Debt (Q1) (Mil) | $0 | $4 | 0% |
|
| Enterprise Value (Q1) (Mil) | na | $164 | na |
|
| Valuation | BYSI | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.83 | na |
|
| P/E | na | 19.6 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.0 | na |
|
| Ratios | BYSI | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 64.2% | na |
|
| Net Margin | na | (75.9%) | na |
|
| ROA | (29.3%) | (47.5%) | 17% |
|
| ROE | 20.3% | (55.0%) | 80% |
|
| Liabilities to Assets | 346.6% | 29.6% | 100% |
|
| F-Score | 1 | 3 | 1% |
|
BeyondSpring Inc. did not pass any screens on 8/21/2026.
